Physician profile
Bryan L Witt
NPI 1508002726
$1,952.27
in general payments reported to CMS, 2019-2025
10 companies · $570 in 2025
The $570 reported for 2025 was less than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $185 · 2020: $614 · 2021: $452 · 2022: $110 · 2024: $21.35 · 2025: $570.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $296 · Travel and Lodging: $228 · Education: $67.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $296.42 |
| Travel and Lodging | $227.82 |
| Education | $67.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $903.23 | 2021-2025 | Oxford, Oxford Partial Knee |
| Arthrex, INC. | $582.09 | 2020 | |
| Orthofix Medical, INC. | $141.91 | 2019-2021 | |
| Depuy Synthes Sales INC. | $76.73 | 2021-2022 | |
| Wright Medical Technology, INC. | $67.40 | 2019 | |
| Djo, LLC | $57.92 | 2022-2024 | Cmf |
| Integra Lifesciences Corporation | $35.10 | 2021 | |
| Ossur Americas, INC. | $33.23 | 2025 | Unloader One X |
| Si-Bone, INC. | $30.98 | 2021 | |
| Kci USA, INC. | $23.68 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Witt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.